Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm

Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01024907	Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas	completed	Phase 1 / Phase 2	23	Abramson Cancer Center at Penn MedicineOTHER	1	Dec 10, 2020	clinicaltrials
NCT01119599	RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma	completed	Phase 1	22	National Cancer Institute (NCI)NIH	1	Sep 29, 2015	clinicaltrials
NCT01082926	Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2	completed	Phase 1	6	City of Hope Medical CenterOTHER	1	Jun 8, 2015	clinicaltrials

Data updated 23 days agoSource updated Dec 10, 2020source: clinicaltrials